Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Efinaconazole

    Client Email Product

    Efinaconazole

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    31
    US DMFs Filed

    US DMFs Filed

    21
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    4
    Other Certificates

    Other Certificates

    3
    Other Suppliers

    Other Suppliers

    21
    API REF. PRICE (USD / KG)
    7,290

    API Market Place

    12
    INTERMEDIATES
    4
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    8
    Europe

    Europe

    0

    Canada

    Canada

    1
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    267.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    1
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    18

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    36
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    4
    SERVICES

    0

    Full View ScreenFull Screen View
    Zydus Pharm Generic Fingolimod HCL Receives Tentative Approval in the U.S.
    Zydus Pharm Generic Fingolimod HCL Receives Tentative Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212178

    FDA
    15 Jul 2022
    Share Share
    Lupin receives USFDA approval for anti-fungal drug
    Lupin receives USFDA approval for anti-fungal drug

    https://www.business-standard.com/article/news-cm/lupin-receives-usfda-approval-for-anti-fungal-drug-122030300756_1.html

    BUSINESS-STANDARD
    03 Mar 2022
    Share Share
    Lupin Ltd's Generic Efinaconazole Receives Approval in the U.S.
    Lupin Ltd's Generic Efinaconazole Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212169

    FDA
    02 Mar 2022
    Share Share
    Acrux Dds's Generic Efinaconazole Receives Approval In US
    Acrux Dds's Generic Efinaconazole Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211969

    FDA
    23 Jun 2021
    Share Share
    Aleor gets tentative USFDA approval for Efinaconazole Topical
    Aleor gets tentative USFDA approval for Efinaconazole Topical

    https://www.expresspharma.in/drug-approvals/aleor-dermaceuticals-gets-tentative-usfda-approval-for-efinaconazole-topical-solution/#:~:text=Alembic%20Pharmaceuticals%20announced%20that%20its,Efinaconazole%20Topical%20Solution%2C%2010%25.

    EXPRESSPHARMA.IN/DRUG-APPROVALS/ALEOR-DERMACEUTICALS-GETS-TENTATIVE-USFDA-APPROVAL-FOR-EFINACONAZOLE-TOPICAL-SOLUTION/#:~:TEXT=ALEMBIC%20PHARMACEUTICALS%20ANNOUNCED%20THAT%20ITS,EFINACONAZOLE%20TOPICAL%20SOLUTION%2C%2010%25
    08 Apr 2021
    Share Share
    Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19
    Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-seeks-govt-nod-to-start-phase-iii-clinical-trials-of-covid-19-vaccine/articleshow/79944764.cms

    ECONOMICTIMES
    23 Dec 2020
    Share Share
    Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19
    Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-seeks-govt-nod-to-start-phase-iii-clinical-trials-of-covid-19-vaccine/articleshow/79944764.cms

    ECONOMIC TIMES
    23 Dec 2020
    Share Share
    Perrigo Pharma`s Generic Efinaconazole Receives Approval in US
    Perrigo Pharma`s Generic Efinaconazole Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211851

    FDA
    22 Dec 2020
    Share Share
    Global Efinaconazole Market Expected to Reach USD 875 Million by 2026
    Global Efinaconazole Market Expected to Reach USD 875 Million by 2026

    http://galusaustralis.com/2020/03/548781/global-efinaconazole-market-expected-to-reach-usd-875-million-by-2026/

    Milind GALUSAUSTRALIS
    20 Mar 2020
    Share Share
    Teva Pharms` Generic Efinaconazole Receives Tentative Approval in US
    Teva Pharms` Generic Efinaconazole Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211827

    FDA
    18 Oct 2019
    Share Share
    Perrigo Announces Patent Litigation Settlement for Generic Version of Jublia
    Perrigo Announces Patent Litigation Settlement for Generic Version of Jublia

    https://www.prnewswire.com/news-releases/perrigo-announces-patent-litigation-settlement-for-the-generic-version-of-jublia-topical-solution-10-300794988.html

    PR NEWSWIRE
    14 Feb 2019
    Share Share
    Temad Co from Brasov looks to expand to Caucasus after sales up 7%
    Temad Co from Brasov looks to expand to Caucasus after sales up 7%

    https://www.zf.ro/business-construct/temad-co-din-bra-sov-se-uita-la-extindere-spre-zona-caucazului-dupa-ce-vanzarile-au-crescut-cu-7-15005062

    ZF
    29 Jan 2019
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Mylan
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Mylan

    https://insight.rpxcorp.com/litigation_documents/13080857

    PATENT LITIGATION
    02 Oct 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. KVK-Tech
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. KVK-Tech

    https://insight.rpxcorp.com/litigation_documents/13080858

    PATENT LITIGATION
    02 Oct 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma

    https://insight.rpxcorp.com/litigation_documents/13084844

    PATENT LITIGATION
    02 Oct 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Cipla Ltd.
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Cipla Ltd.

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-v-cipla-ltd-1537861101.pdf

    PATENT LITIGATION
    25 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Acrux DDS Pty Ltd.
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Acrux DDS Pty Ltd.

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-v-acrux-dds-pty-ltd-1537861150.pdf

    PATENT LITIGATION
    25 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Perrigo Pharma
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Perrigo Pharma

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-v-perrigo-pharma-1537861409.pdf

    PATENT LITIGATION
    24 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Apotex Corp.
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Apotex Corp.

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-v-apotex-corp-1537861371.pdf

    PATENT LITIGATION
    24 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Macleods Pharma
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Macleods Pharma

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-v-macleods-pharma-1537861331.pdf

    PATENT LITIGATION
    24 Sep 2018
    Share Share
    Jublia (efinaconazole): Valeant Pharma, Dow Pharma, Kaken v. Aleor Dermaceutical
    Jublia (efinaconazole): Valeant Pharma, Dow Pharma, Kaken v. Aleor Dermaceutical

    https://insight.rpxcorp.com/litigation_documents/13069565

    PATENT LITIGATION
    22 Sep 2018
    Share Share
    Jublia (efinaconazole) :Valeant Pharmaceuticals vs. Teva Pharma USA
    Jublia (efinaconazole) :Valeant Pharmaceuticals vs. Teva Pharma USA

    https://insight.rpxcorp.com/litigation_documents/13075659

    PATENT LITIGATION
    22 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Aurobindo Pharma
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Aurobindo Pharma

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-v-aurobindo-pharma-1536992124.pdf

    PATENT LITIGATION
    15 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Strides Pharma
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Strides Pharma

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-v-strides-pharma-1536992185.pdf

    PATENT LITIGATION
    15 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Alkem Labs
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Alkem Labs

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-pharma-v-alkem-labs-1536992279.pdf

    PATENT LITIGATION
    15 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Lupin
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Lupin

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-kaken-pharma-v-lupin-1536992475.pdf

    PATENT LITIGATION
    15 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharmac v. Par Pharmaceutical
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharmac v. Par Pharmaceutical

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharmac-v-par-pharmaceutical-1536921260.pdf

    PATENT LITIGATION
    11 Sep 2018
    Share Share
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma vs. Zydus Pharma
    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma vs. Zydus Pharma

    https://www.pharmacompass.com/pdf/news/jublia-efinaconazole-valeant-pharma-dow-pharma-vs-zydus-pharma-1536921283.pdf

    PATENT LITIGATION
    07 Sep 2018
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Jublia 203567 (Efinaconazole) Topical Solution
    FDA Confirms Paragraph IV Patent Challenge of Jublia 203567 (Efinaconazole) Topical Solution

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-jublia-203567-efinaconazole-topical-solution-1533186961.pdf

    FDA
    01 Aug 2018
    Share Share
    Argentum Wins Patent Invalidation Trial Against Patent on Valeant's JUBLIA®
    Argentum Wins Patent Invalidation Trial Against Patent on Valeant's JUBLIA®

    https://www.prnewswire.com/news-releases/argentum-pharmaceuticals-wins-patent-invalidation-trial-against-patent-on-valeants-jublia-300662242.html

    PR NEWSWIRE
    07 Jun 2018
    Share Share
    Valeant Pharmaceuticals Comments On Management Change
    Valeant Pharmaceuticals Comments On Management Change

    http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-comments-on-management-change-300230215.html

    PR NEWS WIRE
    03 Mar 2016
    Share Share
    Drug Spending Slowed in 2015 After Discounts, CVS Health Says
    Drug Spending Slowed in 2015 After Discounts, CVS Health Says

    http://www.bloomberg.com/news/articles/2016-02-23/drug-spending-slowed-in-2015-after-discounts-cvs-health-says

    Robert Langreth BLOOMBERG
    24 Feb 2016
    Share Share
    Valeant, AstraZeneca played the Super Bowl ad game, but did they win?
    Valeant, AstraZeneca played the Super Bowl ad game, but did they win?

    http://www.fiercepharmamarketing.com/story/valeant-astrazeneca-played-super-bowl-ad-game-did-they-win/2016-02-08

    Beth Snyder Bulik FIERCE PHARMA MARKETING
    08 Feb 2016
    Share Share
    Valeant Announces New U.S. Fulfillment Agreements With Walgreens
    Valeant Announces New U.S. Fulfillment Agreements With Walgreens

    http://www.prnewswire.com/news-releases/valeant-announces-new-us-fulfillment-agreements-with-walgreens-plans-to-further-extend-distribution-to-independent-pharmacies-300192840.html

    PR NEWS WIRE
    16 Dec 2015
    Share Share
    Exclusive: U.S. drug benefit managers clamp down on specialty pharmacies
    Exclusive: U.S. drug benefit managers clamp down on specialty pharmacies

    http://www.reuters.com/article/2015/11/15/us-healthcare-pharmacies-terminations-ex-idUSKCN0T40WF20151115#REQY6Dg2pHX8S1gw.97

    Caroline Humer REUTERS
    16 Nov 2015
    Share Share
    Emmy co-host Mario Lopez spotlights Valeant's Jublia on the red carpet
    Emmy co-host Mario Lopez spotlights Valeant's Jublia on the red carpet

    http://www.fiercepharmamarketing.com/story/emmy-co-host-mario-lopez-spotlights-valeants-jublia-red-carpet/2015-09-23

    Beth Snyder Bulik FIERCE PHARMA MARKETING
    23 Sep 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Virupaksha Efinaconazole

    Access Virtual Booth

    Contact Supplier

    View Presentation

    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search